Sort by
Refine Your Search
-
at the VIB-KU Leuven Center for Brain & Disease Research, is looking for a full-time Research Technician to support our cutting-edge research on brain development and play a central role in lab operations. We
-
, service-minded and eager to learn, with the ability to manage multiple priorities in an academic environment. Responsibilities You act as the primary contact for administrative queries, offering guidance
-
and Delivery: Design and develop training programs on Data Science and AI topics, including machine learning algorithms, data visualization, and statistical analysis. Provide foundational sessions about
-
innovative technologies. The VIB Technologies comprises multiple state-of-the-art core facilities, each with a specific technology focus and embedded within the VIB centers in Ghent, Leuven, or Brussels
-
, onboarding materials). Foster a security-by-design culture in collaboration with ICT and research units, promoting early engagement in tool development and procurement. Actively engage with stakeholders across
-
of biosamples from neurodegenerative disease patients and healthy controls and will assist with the development and execution of custom genetic assays aimed at novel gene discovery. Routinely used techniques will
-
. The candidate will work in a team of scientists dedicated to develop antisense oligonucleotides as disease-modifying therapeutics for neurodegenerative diseases. Our strategy is based on an innovative, all-in
-
departments; building strong relationships with translational stakeholders, including academic hospitals, universities and research organizations; developing VIB-wide supportive activities related
-
Learning Expertise Unit at VIB.AI. Your role As an LLM Engineer, you will: Develop and deploy pilot projects in close collaboration with and tailored to VIB’s domain-specific centers, applying LLMs
-
At PFx Biotech, we are driving the next frontier in advanced nutrition by harnessing the power of biology and using precision fermentation to develop and launch bioactive specialty proteins